China online Medical B2B, Global trade platform!
企业入驻 My Member Message Center
International
  • English
  • العربية
  • Русский
  • Español
  • Français
  • India
Get the APP
  • Android
  • los
  • Medical Trend
  • Trade fairs
  • Market Reports
  • Trade Policies
Join Free

trending topics

Clinical TrialsCompany InsightDongsin CollegeDongsin NewsExhibitions & ActivitiesMarket ReportsMarket ViewsNew Approvals

hot tags

Credit VerificationInnovationMedical DeviceMedicaArab healthAntibodyCancerACTDCPHLEMAFDAEU

market reports

  • MEDICAL JAPAN 2025 OSAKA Returns to Showcase Global Innovations

    2025-02-17

  • Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!

    2023-09-01

  • US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight

    2022-01-21

  • Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines

    2022-01-21

  • Hong Kong researchers say they develop novel material able to kill COVID-19 virus

    2022-01-14

  • 10 million more Chinese doses on way for Kenya

    2022-01-14

  • Sino-African ties on track for a brighter future

    2022-01-07

  • Efforts urged to boost COVID-19 vaccine production capacity in poor countries

    2022-01-07

  • UAE approves Sinopharm's new protein-based COVID-19 vaccine

    2022-01-07

  • UAE approves Sinopharm's new protein-based COVID-19 vaccine

    2022-01-07

  • China approves patent to COVID-19 vaccine

    China has granted its first COVID-19 vaccine patent to the adenovirus vector vaccine developed by Chen Wei of the Academy of Military Medical Sciences and Chinese biotech company CanSino Biologics.

    2020-08-20
    Innovation
  • China-developed COVID-19 vaccine ready to go onto market this Dec

    Inactivated COVID-19 vaccine candidates developed by a Chinese pharmaceutical company are likely to be on the market by the end of December, at a price of less than 1,000 yuan ($144) for two doses.

    2020-08-19
    Innovation
  • Six COVID-19 vaccine candidates, including 3 from China, now in phase-3 trials: WHO

    Six COVID-19 vaccine candidates, including three from China, have entered phase-3 trials, a senior World Health Organization (WHO) official said on Thursday.

    2020-08-07
    Innovation
  • Trials of a vaccine and new drug raise hope of beating covid-19

    The latest tests with Oxford University’s vaccine, and interferon beta, look promising

    2020-08-05
    Innovation
  • Clinical trials continue for China's self-developed AIDS vaccine

    A multi-center clinical trial for China's self-developed AIDS vaccine started this year and is currently in progress, according to the National Health Commission.

    2020-07-10
    Innovation
  • Medical equipment makers step up innovation

    China's medical manufacturing industry managed to maintain its momentum amid the COVID-19 pandemic, while boosting nation's efforts of bettering its manufacturing sector and its role in the global medical supply chain, industry experts said.

    2020-06-23
    InnovationMedical Device
  • Chinese-developed inactivated COVID19 vaccine becomes 1st worldwide to report positive response

    A Chinese-developed inactivated vaccine for COVID-19 has presented positive preliminary results in phase one and two clinical trials, becoming the first vaccine candidate in the world to show favorable immunogenicity and safety.

    2020-06-18
    Innovation
  • COVID-19 vaccine could arrive before year's end

    Two COVID-19 vaccine candidates with the China National Biotec Group (CNBG) have been proven safe in current clinical trials and could be available by the end of the year or early 2021, Yang Xiaoming, president of CNBG said in a report on Thursday.

    2020-05-18
    Innovation
  • Innovation helps stop COVID-19 at China's borders

    BEIJING, April 15 (Xinhua) -- "Ding!" It's the sound of Customs officers scanning the electronic health codes of travelers in the exit-entry hall before allowing them into the country.

    2020-04-16
    Innovation
  • Shanghai scientists make discovery in gene editing approach

    Shanghai scientists have found in lab tests that a novel gene editing approach could for the first time regenerate retinal ganglion cells and therefore restore sight of mice that suffer from permanent visual impairment.

    2020-04-09
    Innovation
Prev 1 2 Next
  • Easy Sourcing

    Multillingual operation; 30 seconds quick enquiry; Platform customer service team

  • Quality Statement

    All suppliers are genuine and verified China medical manufacturers or traders. 100% quality guaranted for all products

  • Our Guarantees

    TOP brands; Advanced quality products; Competitive price

  • Services

    Registered BuyerPublish Purchase OrdersExhibition OnlineMatch Making
  • About us

    About Chinamed.cn70+ medical showsSitemapTerms & Conditions
  • Help

    For BuyerFor SupplierFAQContact Us

newsletter

Copyright © 2019 chinamedonline.com All Rights Reserved Design By SmallView
沪ICP备18036926号-8
  • Product
  • Suppliers
  • Exhibition
  • News
  • Medical Trend
  • Trade fairs
  • Market Reports
  • Trade Policies
Sign In Join Free